InterventionsHuman trial
Estimated Lifetime Benefits of Finerenone on Cardiorenal Morbidity and Mortality in Patients with Type 2 Diabetes and Chronic Kidney Disease
AHA Scientific Sessions 2025 Abstract
The paper
John W. Ostrominski, Brendon Lange Neuen, Brian Lee Claggett, Stefan D. Anker
Show 11 more authors
Rajiv Agarwal, Gerasimos Filippatos, Peter R Rossing, Luis Miguel Ruilope, Meike Brinker, Andrea Z. Lage, Patrick Schloemer, Katja Rohwedder, John J.V. McMurray, Scott David Solomon, Muthiah Vaduganathan,Brigham and Women's Hospital · Charité - Universitätsmedizin Berlin
AHA Scientific Sessions 2025 Abstract · 3 Nov 2025
Presented at AHA Scientific Sessions 2025 · Abstract 4369294
